Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2025-12-17 @ 2:44 AM
Study NCT ID:
NCT04668300
Status:
None
Last Update Posted:
2025-10-09 00:00:00
First Post:
2020-08-18 00:00:00
Brief Title:
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
Sponsor:
Organization:
M.D. Anderson Cancer Center
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
75
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: